Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sales of Pharmaceutical Raw Materials	398.23M	463.72M	447.58M	442.87M	420.89M
Production and Sales of Pharmaceutical Raw Materials Growth	-14.12%	3.60%	1.07%	5.22%	14.67%
Total	398.23M	463.72M	447.58M	442.87M	420.89M
Total Growth	-14.12%	3.60%	1.07%	5.22%	14.67%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	194.30M	-	149.99M	202.29M	182.89M
East China Growth	-	-	-25.86%	10.60%	20.10%
North China	82.65M	-	123.90M	71.44M	53.98M
North China Growth	-	-	73.45%	32.35%	-0.17%
Central China	17.92M	-	17.07M	14.00M	33.03M
Central China Growth	-	-	21.89%	-57.61%	-26.47%
Southwest	34.22M	-	30.15M	24.79M	27.58M
Southwest Growth	-	-	21.60%	-10.12%	-11.21%
South China	10.15M	-	15.85M	24.58M	44.16M
South China Growth	-	-	-35.52%	-44.33%	102.08%
Northeast	11.90M	-	7.88M	8.39M	9.13M
Northeast Growth	-	-	-6.10%	-8.07%	-10.58%
Northwest	3.38M	-	5.19M	1.15M	1.37M
Northwest Growth	-	-	352.38%	-16.30%	-23.83%
Overseas	43.71M	-	97.55M	96.22M	68.74M
Overseas Growth	-	-	1.38%	39.98%	38.19%
Total	398.23M	-	447.58M	442.87M	420.89M
Total Growth	-	-	1.07%	5.22%	15.01%

Source: S&P Global Market Intelligence.